COOKE MICHAEL P. 4
4 · Magenta Therapeutics, Inc. · Filed Feb 7, 2019
Insider Transaction Report
Form 4
COOKE MICHAEL P.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-02-05+64,000→ 64,000 totalExercise: $7.13Exp: 2029-02-04→ Common Stock (64,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in 12 equal quarterly installments beginning on January 1, 2019.